Sumitomo Dainippon Pharma Co Financial Overview
Sumitomo Dainippon Pharma Co's market cap is currently $5.41B. The company's EPS TTM is $1.41798901; its P/E ratio is 4.57; Sumitomo Dainippon Pharma Co is scheduled to report earnings on October 31, 2025, and the estimated EPS forecast is $-0.01. See an overview of income statement, balance sheet, and cash flow financials.
